Article
New Orleans - Determining the relative risk of a cutaneous drug reaction pattern is vital to determining whether the drug(s) in question can be continued currently or rechallenged in the future,
Day 2 Recap: SBS 2025
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Chilukuri’s Approach to Safer Aesthetic Treatments
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Nutraceuticals: A Boost for Skin Health
Naiem Issa, MD, PhD, FAAD, Discusses Holistic Hair Loss Treatments at SBS 2025